MIKAYLA GREENWALD: Open Payments
NPI 1326773532 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 65 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $884 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 24 | $215 |
| Novartis Pharmaceuticals Corporation | 7 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Calliditas Therapeutics US Inc. | 2 | $58 |
| Fresenius USA Marketing, Inc. | 3 | $49 |
| Vifor Pharma, Inc. | 3 | $44 |
| Amgen Inc. | 3 | $42 |
| Novo Nordisk Inc | 2 | $42 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
Products named: PURIFIED CORTROPHIN GEL, JARDIANCE, Fabhalta, JYNARQUE, TARPEYO, VELPHORO, Veltassa, TAVNEOS.
Industry payments across NE — which companies pay providers there.
